SCHEMBL15865412

SCHEMBL15865412

COc1ccc(OC(F)F)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 11/20 0.48
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ MEN1 O00255 10/20 0.46
▸ KMT2A Q03164 10/20 0.46
▸ ALDH1A1 P00352 6/20 0.46
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA7 P43166 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ CA14 Q9ULX7 1/20 0.45
▸ POLB P06746 2/20 0.44
▸ SLC6A4 P31645 4/20 0.43
▸ SLC6A2 P23975 2/20 0.43
▸ SLC6A3 Q01959 2/20 0.43
▸ HTT P42858 4/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29587997 0.80 CA12 (0.62) MAPTMEN1KMT2AALDH1A1CA12
SCHEMBL197088 0.80 CA12 (0.62) MAPTMEN1KMT2AALDH1A1CA12
SCHEMBL16953984 0.79 MAPT (0.48) MAPTMEN1KMT2AALDH1A1CA12
SCHEMBL6002589 0.78 CA12 (0.60) MAPTMEN1KMT2AALDH1A1CA12
SCHEMBL27932793 0.78 MAPT (0.63) MAPTRAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL16953981 0.78 CA12 (0.45) MAPTNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL27931862 0.77 MRGPRX4 (0.46) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL293964 0.77 MEN1 (0.51) MAPTNPC1RAB9ASMN1; SMN2MEN1
Nitrogen SCHEMBL11366394 0.76 CA12 (0.58) MAPTMEN1KMT2AALDH1A1CA12
SCHEMBL12093570 0.76 CA12 (0.47) MAPTSMN1; SMN2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150336866-A1 SYNTHESIS OF DIFLUOROMETHYL ETHERS AND SULFIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2015-11-26 — — US disclosed
US-20150336866-A1 SYNTHESIS OF DIFLUOROMETHYL ETHERS AND SULFIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2015-11-26 — — US disclosed
WO-2014107380-A1 SYNTHESIS OF DIFLUOROMETHYL ETHERS AND SULFIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-07-10 — — WO disclosed
WO-2014107380-A1 SYNTHESIS OF DIFLUOROMETHYL ETHERS AND SULFIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-07-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336866-A1 SYNTHESIS OF DIFLUOROMETHYL ETHERS AND SULFIDES DDT, ABL1, TYR MAPT 3810/4885NPC1 3297/4885RAB9A 3577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback